Clinical Trial: A Single-Dose Study in Normal Volunteers to Assess the Safety, Tolerability and Pharmacokinetics of STX107

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: A Single-Dose, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study in Healthy, Normal Volunteers to Assess the Safety, Tolerability and Pharmacokinetics of STX107

Brief Summary: The objectives of this study are to determine the safety and tolerability of single oral doses of STX107 and to determine basic pharmacokinetic (PK) parameters following single oral doses of STX107 when administered via an oral suspension

Detailed Summary:
Sponsor: Seaside Therapeutics, Inc.

Current Primary Outcome: Adverse events [ Time Frame: During the course of the study and for 14 days after completing the study ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Seaside Therapeutics, Inc.

Dates:
Date Received: August 24, 2009
Date Started: September 2009
Date Completion:
Last Updated: February 5, 2010
Last Verified: February 2010